OPIS is an European clinical CRO providing premium support for the management of global clinical trials from phase I to IV as well as pre- and post-marketing medical device investigations.
Founded in 1998, the company has 20 years of extensive experience in a wide range of therapeutic areas. Its recent oncology/immuno-oncology portfolio amounts to over 400 trials.
OPIS’s strength lies in its people and its specialized teams who assist clients from A-Z with medical writing, scientific and statistical consultancy for trial design and skilled teams of operational staff across Europe that ensure high quality project execution.
The OPIS e-clinical suite is developed to streamline digitalization of clinical data. Fully FDA 21 CRF Part 11 compliant and developed in close collaboration with the OPIS biometry and clinical operations units it offers:
• CLINICAL.NET, a modular and extremely user-friendly platform to handle all clinical trial data.
• A consolidated platform to handle named-patient programmes digitally.
• An investigator toolkit to facilitate and coordinate patient and clinician participation in clinical trials.
With flexible business models, OPIS clients come first and offers are truly shaped around individual Sponsor needs.
The OPIS teams are passionate about what they do and OPIS wants its name to stand for excellence.